Azacitidine Injection · 2,093 days since initial FDA posting
Brand: AZACITIDINE
FDA lists Azacitidine Injection as Active Shortage (Dr. Reddy's Laboratories, Inc.).
Availability on file: Available
Azacitidine Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Azacitidine Injection
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Dosage Form
- Injection
- Presentation
- Azacitidine, Injection, 100 mg (NDC 43598-305-62)
- Package NDC
- 43598-305-62
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Dec 18, 2020
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Oncology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Available to existing customers
Nearby, Other Azacitidine Shortage Records
Azacitidine Injection
Meitheal Pharmaceuticals, Inc.
Injection
Azacitidine Injection
Eugia US LLC
Injection
Azacitidine Injection
Fresenius Kabi USA, LLC
Injection
Azacitidine Injection
Bristol Myers Squibb Co.
Injection
Azacitidine Injection
Accord Healthcare Inc.
Injection
Azacitidine Injection
Teva Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Available to existing customers. General shortage guidance lives on the tracker hub.